VEZF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.843800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.897400E-01
Normal-vs-Stage2
3.598000E-01
Normal-vs-Stage3
1.098760E-01
Normal-vs-Stage4
6.971600E-01
Stage1-vs-Stage2
2.874800E-01
Stage1-vs-Stage3
1.476170E-02
Stage1-vs-Stage4
8.040200E-01
Stage2-vs-Stage3
7.78580000027063E-07
Stage2-vs-Stage4
5.336600E-01
Stage3-vs-Stage4
3.815200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.450200E-01
Normal-vs-AfricanAmerican
7.969000E-01
Normal-vs-Asian
1.812160E-01
Caucasian-vs-AfricanAmerican
5.523900E-02
Caucasian-vs-Asian
3.487200E-01
AfricanAmerican-vs-Asian
8.295700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.190400E-01
Normal-vs-Female
3.612400E-01
Male-vs-Female
9.263800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.468000E-01
Normal-vs-Age(41-60Yrs)
7.610800E-01
Normal-vs-Age(61-80Yrs)
2.641800E-01
Normal-vs-Age(81-100Yrs)
5.652400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.035200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.299200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.556300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.043100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.362200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.103200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.192400E-02
Normal-vs-Daily Drinker
4.922300E-02
Normal-vs-Weekly Drinker
1.426420E-01
Normal-vs-Occasional Drinker
7.805600E-01
Normal-vs-Social Drinker
6.808200E-01
Non Drinker-vs-Daily Drinker
8.700200E-01
Non Drinker-vs-Weekly Drinker
8.459200E-01
Non Drinker-vs-Occasional Drinker
1.363520E-02
Non Drinker-vs-Social Drinker
1.736230E-02
Daily Drinker-vs-Weekly Drinker
9.466200E-01
Daily Drinker-vs-Occasional Drinker
3.423600E-02
Daily Drinker-vs-Social Drinker
2.490400E-02
Weekly Drinker-vs-Occasional Drinker
8.208400E-02
Weekly Drinker-vs-Social Drinker
8.647900E-02
Occasional Drinker-vs-Social Drinker
8.829400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.306000E-02
Normal-vs-Grade 2
1.373510E-02
Normal-vs-Grade 3
7.023700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.267400E-01
Grade 1-vs-Grade 3
9.875000E-01
Grade 1-vs-Grade 4
7.306000E-02
Grade 2-vs-Grade 3
3.157200E-01
Grade 2-vs-Grade 4
1.373510E-02
Grade 3-vs-Grade 4
7.023700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.338170E-01
Normal-vs-NonDiabetic
3.422000E-01
Diabetic-vs-NonDiabetic
1.752560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.974250E-01
Normal-vs-NoPancreatitis
3.053400E-01
Pancreatitis-vs-NoPancreatitis
6.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.344400E-01
Normal-vs-N1
3.607400E-01
N0-vs-N1
9.906000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.737800E-01
Normal-vs-TP53-NonMutant
8.086400E-01
TP53-Mutant-vs-TP53-NonMutant
5.811600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
